IBEX 35
11.404,90 -39,10 (-0,34%) Euro Stoxx 50
5.051,31 -17,78 (-0,35%) Dólar/Euro
1,0804 -0,0091 (-0,83%) Petróleo Brent
79,49 -0,38 (-0,48%) Oro
2.311,10 -79,80 (-3,34%) Bitcoin EUR
64.077,49 -71,61 (-0,11%)
Lifeline Biotechnologies, Inc. (LLBO)
Lifeline Biotechnologies, Inc.
1325 Airmotive Way
Suite 175
Reno, NV 89502
United States
775-852-3222
https://www.lbti.co
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. James D. Holmes CPA, MBA | Chairman, Chief Executive Officer and Treasurer | N/A | N/A | N/A |
| Dr. William H. Reeves Ph.D. | Founder | N/A | N/A | N/A |
| Dr. Louis G. Keith M.D., Ph.D. | Vice President, Medical Director, Secretary and Director | N/A | N/A | N/A |
Descripción
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Gobierno corporativo
El ISS Governance QualityScore de Lifeline Biotechnologies, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
